Updated: Myriad Genetics to Participate in Two Upcoming Investor Healthcare Conferences

Core Insights - Myriad Genetics, Inc. is a leader in molecular diagnostic testing and precision medicine, focusing on advancing health and well-being through innovative testing solutions [2] Group 1: Company Overview - Myriad Genetics develops molecular tests that assess disease risk and guide treatment decisions, significantly improving patient care and reducing healthcare costs [2] Group 2: Upcoming Events - Management plans to participate in the BofA Securities 2025 Health Care Conference on May 14, 2025, at 6:00 pm ET [3] - The company will also participate in the Goldman Sachs 46th Annual Global Healthcare Conference on June 11, 2025, at 2:00 pm ET [3]